Fiduciary Family Office’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.77M Buy
15,413
+6,106
+66% +$1.42M 1.07% 13
2025
Q4
$1.93M Sell
9,307
-628
-6% -$124K 0.55% 34
2025
Q3
$1.84M Sell
9,935
-266
-3% -$45.6K 0.52% 36
2025
Q2
$1.56M Buy
10,201
+1,109
+12% +$170K 0.51% 37
2025
Q1
$1.51M Buy
+9,092
New +$1.42M 0.5% 36
2024
Q4
Sell
-9,654
Closed -$1.56M 166
2024
Q3
$1.56M Buy
9,654
+1,004
+12% +$160K 0.52% 40
2024
Q2
$1.26M Sell
8,650
-1,576
-15% -$234K 0.5% 47
2024
Q1
$1.62M Sell
10,226
-155
-1% -$24.7K 0.63% 39
2023
Q4
$1.63M Buy
+10,381
New +$1.59M 0.71% 25

Other funds holding JNJ

Fiduciary Family Office's JNJ Position: Q1 2026 in Review

Fiduciary Family Office increased its Johnson & Johnson (JNJ) stake by 66% in Q1 2026, buying an estimated $1.42M and bringing the position to 15,413 shares worth $3.77M. The position accounts for 1.07% of the portfolio, ranked #13.

Fiduciary Family Office first reported a position in JNJ in Q4 2023 and has held it in 9 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Fiduciary Family Office held 15,413 shares of Johnson & Johnson worth $3.77M as of Q1 2026.
  • Fiduciary Family Office bought 6,106 Johnson & Johnson shares in Q1 2026, an estimated $1.42M.
  • Johnson & Johnson made up 1.07% of Fiduciary Family Office's portfolio in Q1 2026, its #13 holding.
  • Fiduciary Family Office first reported a position in Johnson & Johnson in Q4 2023 and has held it in 9 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Fiduciary Family Office's 13F filing for Q1 2026, filed 14 May 2026.